Your browser doesn't support javascript.
loading
Targeted i.v. BU and fludarabine (t-i.v. BU/Flu) provides effective control of AML in adults with reduced toxicity.
Pidala, J; Kim, J; Anasetti, C; Kharfan-Dabaja, M A; Field, T; Perkins, J; Ayala, E; Perez, L; Fernandez, H.
Affiliation
  • Pidala J; Department of Blood and Marrow Transplantation, Moffitt Cancer Center, University of South Florida, Tampa, FL 33612, USA. joseph.pidala@moffitt.org
Bone Marrow Transplant ; 46(5): 641-9, 2011 May.
Article in En | MEDLINE | ID: mdl-20711242
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vidarabine / Busulfan / Leukemia, Myeloid, Acute / Myeloablative Agonists Type of study: Prognostic_studies Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2011 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vidarabine / Busulfan / Leukemia, Myeloid, Acute / Myeloablative Agonists Type of study: Prognostic_studies Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Bone Marrow Transplant Journal subject: TRANSPLANTE Year: 2011 Document type: Article Affiliation country: United States